Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthrac… (NCT07426913) | Clinical Trial Compass
RecruitingNot Applicable
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
United States30 participantsStarted 2026-05-20
Plain-language summary
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years of age or older
* Able to speak and read in English
* Actively receiving Trastuzumab or an anthracycline-based treatment
* Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.
* Diagnosed with stages 0-III Breast Cancer
Exclusion Criteria:
\- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since I'm receiving anthracyclines or trastuzumab, how concerned should I be about the heart-related side effects this trial is focused on educating about, and how would joining this study affect my regular monitoring for those risks?
2This trial is measuring how well a virtual reality tool teaches breast cancer survivors about cardiotoxicity — it's not testing a new drug or procedure, so would participating in any way change or interfere with my actual cancer treatment plan?
3The trial is in a 'not applicable' phase, which suggests it's more of an educational or behavioral study than a medical intervention — can you help me understand what I'd actually be asked to do, and how much time and technology access that would realistically require from me?
4Since the study is measuring things like usability and satisfaction with the VR tool rather than health outcomes, what would I personally gain from participating compared to just receiving standard education about heart health from my care team?
5Are there patients for whom you'd recommend focusing entirely on standard cardiotoxicity monitoring rather than spending time on a study like this — and do you think my current situation makes me a good fit to even consider it?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
CTRCD Knowledge
Timeframe: Baseline, within 2 days post-Intervention, and 4 weeks post-intervention